Where MedTech Commercial ROI Breaks
4 min read • February 28, 2025
David - CEO
Even when MedTech companies improve their visibility into the field, a harder question remains: why do so many well-intentioned commercial investments still fail to deliver meaningful ROI?
I’ve met countless smart MedTech commercial leaders who invested time and effort into shaping thoughtful strategies and securing budgets. Market segmentation, competitive positioning, territory alignment, forecast rigor, enablement initiatives, CRM upgrades, and more recently AI pilots - none of this “just happens.” These initiatives are debated, modeled, reviewed, and approved carefully.
Yet, six or twelve months later, the commercial impact is underwhelming. Pipelines look similar. Growth doesn’t compound. ROI, when measured, is disappointing.
The Friction Between Strategy and Execution
In most cases, the issue is not that the strategy, the technology, or the training were wrong. The issue is that the path to consistent execution had too much friction and not enough immediate value.
Execution depends on small behaviors, repeated daily, at scale, producing instant gratification. When those behaviors require additional administrative steps - opening the laptop at night, logging into another system, updating fields after the fact, piecing disparate bits of data together, reconstructing conversations from memory, and when no instant benefit is felt - consistency erodes. Too often, the first experience a rep has with a new investment is not improved selling or reduced admin - it is additional work. The strategy remains intact on paper and the tools remain powerful in theory, but execution weakens quietly.
This is how investments quietly turn into shelfware. The organization continues paying for licenses, training refreshers, and feature upgrades, further diminishing the ROI while consistent usage never materializes. If your stack is not changing behavior in the field, it is depreciating, not compounding.
Where AI Changes the Equation
In the last month, there has been a tectonic shift in AI and Agentic capability. It is now possible to activate excellent, insightful, knowledge work in real time - as it is needed and on the go. So the real question is not whether to invest in strategy, or new tools. It is whether those investments are designed to live where work actually happens - and most importantly - where your company meets the customer … in the flow of the field, not at the end of the day on a laptop. Today’s Agents, built on a compliant, enterprise knowledge fabric can do exactly that.
Because ROI does not emerge from presentations, dashboards, or feature lists. It emerges from consistent, excellent and insightful frontline behavior - and AI now makes that consistency achievable at scale.
Oleg - CTO
From a technical perspective, most MedTech organizations are not lacking capability. They already run sophisticated CRMs, analytics environments, enablement libraries, and reporting stacks. The data systems exist. The dashboards exist. The playbooks exist.
The architectural problem is that most of these systems were designed as systems of record - optimized for structured data entry, compliance documentation, and leadership reporting. They assume users will log in intentionally, be able to locate data easily, be willing to update fields deliberately, and maintain accuracy after the fact. That assumption doesn’t align with how field work actually happens.
Reps operate in motion. They move continuously between hospitals, cases, conversations, and decisions throughout the day. When systems require a separate login, a separate interface, or a desktop session to capture what just happened, they compete directly with the rep’s primary responsibility: serving the customer. This is why workflow design matters so much.
Additionally, most systems of record were never designed to codify or activate a company’s institutional knowledge. While they store structured data effectively, much of a company’s accumulated expertise still lives elsewhere - in folders, SharePoints, presentations, PDFs, disconnected spreadsheets, and in individuals’ heads. Sales models, objection handling guidance, acceptable claims language, clinical outcomes data, and service documentation may technically exist, but they are difficult to search and almost impossible to activate in real time during a field interaction.
This creates a second execution gap. Even when data is captured correctly, the rep is still responsible for remembering where knowledge lives, interpreting it correctly, and applying it in context. That cognitive load compounds friction.
Embedding Intelligence at the Point of Work
Modern AI and Agentics now make it possible to embed intelligence AND the company’s knowledge directly into mobile workflows rather than layering it on top of desktop systems. Instead of requiring manual reconstruction, AI can capture context during natural interactions. Instead of prompting separate data entry, it can generate structured outputs automatically. Instead of asking the rep to look for answers and best practices across your company, it can embed your company’s best practices, right at the point of action - in context, with excellence, fully leveraging your entire company’s historical experience and wisdom.
When intelligence and wisdom is embedded at the point of execution - particularly on mobile, where the field actually lives - it reduces friction rather than adding to it … and instantly drives value … for reps, for physicians and for all stakeholders. Compliance guardrails can run in the background. Follow-ups can be triggered (and even executed) automatically. Data can flow into existing systems of record without requiring new habits.
This is where AI and, specifically, Agents, unlock ROI - not by replacing your company’s strategy, knowledge or platforms, but by activating them at the point of action. By reducing the friction between intention and action, AI can turn previously underutilized tools into compounding assets rather than static infrastructure.
AI does not guarantee ROI. But when applied at the point of work, it can enable the behavioral consistency that ROI depends on.
If this perspective resonates, we’re always interested in comparing notes with MedTech commercial leaders thinking through similar challenges. Enter your email here and our team will get back to you.